Abstract

The chronic skin inflammation psoriasis is crucially dependent on the IL-23/IL-17 cytokine axis. Although IL-23 is expressed by psoriatic keratinocytes and immune cells, only the immune cell-derived IL-23 is believed to be disease relevant. Here we use a genetic mouse model to show that keratinocyte-produced IL-23 is sufficient to cause a chronic skin inflammation with an IL-17 profile. Furthermore, we reveal a cell-autonomous nuclear function for the actin polymerizing molecule N-WASP, which controls IL-23 expression in keratinocytes by regulating the degradation of the histone methyltransferases G9a and GLP, and H3K9 dimethylation of the IL-23 promoter. This mechanism mediates the induction of IL-23 by TNF, a known inducer of IL-23 in psoriasis. Finally, in keratinocytes of psoriatic lesions a decrease in H3K9 dimethylation correlates with increased IL-23 expression, suggesting relevance for disease. Taken together, our data describe a molecular pathway where epigenetic regulation of keratinocytes can contribute to chronic skin inflammation.

Details

Title
Epigenetic control of IL-23 expression in keratinocytes is important for chronic skin inflammation
Author
Li, Hui 1 ; Yao, Qi 2 ; Alberto Garcia Mariscal 1 ; Wu, Xudong 3 ; Hülse, Justus 1 ; Pedersen, Esben 1 ; Helin, Kristian 3   VIAFID ORCID Logo  ; Waisman, Ari 4   VIAFID ORCID Logo  ; Vinkel, Caroline 5 ; Thomsen, Simon Francis 5 ; Avgustinova, Alexandra 6 ; Salvador Aznar Benitah 6   VIAFID ORCID Logo  ; Lovato, Paola 7 ; Norsgaard, Hanne 7 ; Mortensen, Mette Sidsel 7 ; Veng, Lone 7 ; Rozell, Björn 8 ; Brakebusch, Cord 1 

 Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark; Biotech Research and Innovation Centre (BRIC), Copenhagen, Denmark 
 Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark; Biotech Research and Innovation Centre (BRIC), Copenhagen, Denmark; Center for Healthy Aging, Department of Cellular and Molecular Medicine, University of Copenhagen, Copenhagen, Denmark 
 Biotech Research and Innovation Centre (BRIC), Copenhagen, Denmark; Centre for Epigenetics, Copenhagen, Denmark 
 Institute for Molecular Medicine, Johannes Gutenberg-University Mainz, Mainz, Germany 
 Department of Dermatology, Copenhagen University Hospital Bispebjerg, Copenhagen, Denmark; Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark 
 Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain; Catalan Institution for Research and Advanced Studies (ICREA), Barcelona, Spain 
 LEO Pharma A/S, Ballerup, Denmark 
 Department of Experimental Medicine, University of Copenhagen, Copenhagen, Denmark 
Pages
1-18
Publication year
2018
Publication date
Apr 2018
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2024471362
Copyright
© 2018. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.